Berndt, Ernst R.; Gottschalk, Adrian H. B.; Philipson, Tomas - In: Forum for Health Economics & Policy 8 (2005) 1
Congress enacted and renewed the Prescription Drug User Fee Acts (PDUFA) in 1992, and renewed it in 1997 and 2002, mandating FDA performance goals in reviewing and acting on drug applications within specified time periods. In turn, the FDA was permitted to levy user fees on drug sponsors...
